Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, announced that Danny Brannagan, its Chief Financial Officer,...
Novavax, Inc. , a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced initial data evaluating the immune...
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced that it has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a...
Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system (CNS), announced the publication of Phase 2 data from the...
Scientists have harnessed T-cell to better understand the immune response to mRNA vaccines against SARS-CoV-2, the virus that causes COVID-19. The findings from St....
